Trexquant Investment’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-2,388
| Closed | -$594K | – | 1344 |
|
2020
Q3 | $594K | Sell |
2,388
-1,543
| -39% | -$384K | 0.04% | 614 |
|
2020
Q2 | $1.37M | Sell |
3,931
-646
| -14% | -$224K | 0.09% | 300 |
|
2020
Q1 | $1.23M | Buy |
4,577
+2,715
| +146% | +$727K | 0.09% | 346 |
|
2019
Q4 | $603K | Buy |
+1,862
| New | +$603K | 0.04% | 504 |
|
2018
Q4 | – | Sell |
-4,623
| Closed | -$4.23M | – | 1220 |
|
2018
Q3 | $4.23M | Sell |
4,623
-371
| -7% | -$339K | 0.32% | 87 |
|
2018
Q2 | $3.66M | Buy |
4,994
+4,759
| +2,025% | +$3.49M | 0.25% | 126 |
|
2018
Q1 | $374K | Buy |
+235
| New | +$374K | 0.03% | 728 |
|
2017
Q2 | – | Sell |
-3,806
| Closed | -$1.34M | – | 1054 |
|
2017
Q1 | $1.34M | Buy |
3,806
+170
| +5% | +$59.9K | 0.17% | 152 |
|
2016
Q4 | $669K | Buy |
3,636
+2,095
| +136% | +$385K | 0.11% | 322 |
|
2016
Q3 | $397K | Sell |
1,541
-110
| -7% | -$28.3K | 0.09% | 371 |
|
2016
Q2 | $352K | Buy |
+1,651
| New | +$352K | 0.05% | 605 |
|
2016
Q1 | – | Sell |
-1,160
| Closed | -$293K | – | 1087 |
|
2015
Q4 | $293K | Sell |
1,160
-215
| -16% | -$54.3K | 0.03% | 856 |
|
2015
Q3 | $226K | Sell |
1,375
-278
| -17% | -$45.7K | 0.02% | 941 |
|
2015
Q2 | $310K | Sell |
1,653
-4,107
| -71% | -$770K | 0.03% | 804 |
|
2015
Q1 | $950K | Buy |
5,760
+4,147
| +257% | +$684K | 0.1% | 392 |
|
2014
Q4 | $375K | Buy |
+1,613
| New | +$375K | 0.07% | 589 |
|